Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice

Previous studies using B16BL6-derived exosomes labelled with gLuc–lactadherin (gLuc-LA), a fusion protein of Gaussia luciferase (a reporter protein) and lactadherin (an exosome-tropic protein), showed that the exosomes quickly disappeared from the systemic circulation after intravenous injection in mice. In the present study, the mechanism of rapid clearance of intravenously injected B16BL6 exosomes was investigated. gLuc-LA-labelled exosomes were obtained from supernatant of B16BL6 cells after transfection with a plasmid DNA encoding gLuc-LA. Labelling was stable when the exosomes were incubated in serum. By using B16BL6 exosomes labelled with PKH26, a lipophilic fluorescent dye, it was demonstrated that PKH26-labelled B16BL6 exosomes were taken up by macrophages in the liver and spleen but not in the lung, while PKH26-labelled exosomes were taken up by the endothelial cells in the lung. Subsequently, gLuc-LA-labelled B16BL6 exosomes were injected into macrophage-depleted mice prepared by injection with clodronate-containing liposomes. The clearance of the intravenously injected B16BL6 exosomes from the blood circulation was much slower in macrophage-depleted mice than that in untreated mice. These results indicate that macrophages play important roles in the clearance of intravenously injected B16BL6 exosomes from the systemic circulation.

Abstract licence: CC BY-ND

1. 22.

   Tumor-exosomes and leukocyte activation: an ambivalent crosstalk · 2012

24 more references, whose wording the paper’s licence keeps private.

• Exosome-Based Smart Drug Delivery Tool for Cancer Theranostics · 2023

• Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon–bone healing · 2023

• Exosomal targeting and its potential clinical application · 2022

• Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics · 2022

• Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives · 2022

• Exosomes, a New Star for Targeted Delivery · 2021

• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021

• Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives · 2021

• Corrected

  Bone mesenchymal stem cells stimulation by magnetic nanoparticles and a static magnetic field: release of exosomal miR-1260a improves osteogenesis and angiogenesis · 2021

• Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes · 2021

• Biodistribution of extracellular vesicles following administration into animals: A systematic review · 2021

• Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization · 2021

• MSC-derived exosomes promote recovery from traumatic brain injury via microglia/macrophages in rat · 2020

• Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation · 2020

• Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities · 2020

• Functional assays to assess the therapeutic potential of extracellular vesicles · 2020

• Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice · 2020

• Extracellular vesicles: Natural liver‐accumulating drug delivery vehicles for the treatment of liver diseases · 2020

• Extracellular vesicles in metabolic disease · 2019

• Extracellular vesicle-based drug delivery systems for cancer treatment · 2019

and 10 more

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.